Trexquant Investment LP Sarepta Therapeutics, Inc. Transaction History

Trexquant Investment LP

$7.59 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$113.33 - $163.85 $3.07 Million - $4.44 Million	27,101 Added 210.92%	39,950 $6.31 Million
Q1 2024 May 14, 2024	SELL	$93.7 - $141.53 $5.11 Million - $7.73 Million	-54,584 Reduced 80.95%	12,849 $1.66 Million
Q4 2023 Feb 09, 2024	BUY	$67.31 - $124.76 $4.54 Million - $8.41 Million	67,433 New	67,433 $6.5 Million
Q4 2022 Feb 13, 2023	BUY	$100.86 - $132.13 $64,449 - $84,431	639 Added 2.79%	23,579 $3.06 Million
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $376,581 - $593,099	4,974 Added 27.69%	22,940 $2.54 Million
Q2 2022 Aug 11, 2022	SELL	$62.69 - $88.44 $1.48 Million - $2.09 Million	-23,616 Reduced 56.79%	17,966 $1.35 Million
Q1 2022 May 13, 2022	BUY	$63.15 - $90.42 $1.52 Million - $2.17 Million	24,011 Added 136.65%	41,582 $3.25 Million
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $1.36 Million - $1.75 Million	17,571 New	17,571 $1.58 Million
Q2 2021 Aug 12, 2021	SELL	$69.38 - $86.75 $963,341 - $1.2 Million	-13,885 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$72.25 - $168.95 $706,532 - $1.65 Million	9,779 Added 238.16%	13,885 $1.04 Million
Q4 2020 Feb 11, 2021	SELL	$125.56 - $178.74 $506,760 - $721,394	-4,036 Reduced 49.57%	4,106 $700,000
Q3 2020 Nov 06, 2020	SELL	$127.12 - $172.34 $398,139 - $539,768	-3,132 Reduced 27.78%	8,142 $1.14 Million
Q2 2020 Aug 07, 2020	BUY	$93.0 - $171.7 $1.05 Million - $1.94 Million	11,274 New	11,274 $1.81 Million
Q1 2020 May 08, 2020	SELL	$82.38 - $131.64 $1.74 Million - $2.78 Million	-21,118 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$76.53 - $135.58 $71,172 - $126,089	930 Added 4.61%	21,118 $2.73 Million
Q3 2019 Nov 08, 2019	BUY	$72.81 - $156.91 $1.47 Million - $3.17 Million	20,188 New	20,188 $1.52 Million
Q2 2019 Aug 09, 2019	SELL	$112.21 - $151.95 $378,933 - $513,135	-3,377 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$106.67 - $151.68 $360,224 - $512,223	3,377 New	3,377 $403,000
Q3 2018 Nov 09, 2018	SELL	$115.31 - $161.51 $492,834 - $690,293	-4,274 Closed	0 $0
Q2 2018 Aug 07, 2018	SELL	$71.74 - $153.69 $205,248 - $439,707	-2,861 Reduced 40.1%	4,274 $565,000
Q1 2018 May 03, 2018	BUY	$54.02 - $82.27 $385,432 - $586,996	7,135 New	7,135 $529,000
Q4 2017 Feb 09, 2018	SELL	$47.64 - $56.75 $421,423 - $502,010	-8,846 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$35.73 - $47.15 $316,067 - $417,088	8,846	8,846 $401,000

Others Institutions Holding SRPT

# of Institutions

529

Shares Held

84.2M

Call Options Held

2.06M

Put Options Held

1.52M

Black Rock Inc. New York, NY

10.3M
Shares

$1.23 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

8.97M
Shares

$1.07 Billion
0.02% of portfolio
Capital International Investors Los Angeles, CA

6.26M
Shares

$745 Million
0.16% of portfolio
Janus Henderson Group PLC London, X0

4.36M
Shares

$519 Million
0.29% of portfolio
State Street Corp Boston, MA

4.27M
Shares

$508 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account